Rapid Micro Biosystems, Inc.
NASDAQ:RPIDMedical - Devices
+$0.03 today
- Market cap
- $50.31M
- Beta
- 1.46
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$1.10
Volume 0.17M
Average 0.18M
RPID Retained Earnings
Cumulative profits kept in the business rather than paid out as dividends.
Rapid Micro Biosystems, Inc.NASDAQ: RPID
Retained Earnings · Q1 FY2026 · quarter ended Mar 2026
Retained earnings remains negative
Q1 FY2026 retained earnings was -$536.67M, compared with -$486.54M a year earlier.
Context
- Retained earnings amounted to 860.6% of total assets at the end of Q1 FY2026, up 291.1 pp from a year earlier.
- Retained earnings grew in size in 3 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether retained earnings keeps falling in the next quarterly balance sheet after a -10.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Retained Earnings history
USD · from the balance sheet
- Latest · FY2025
- (522.4M) USD
- Year-over-year change
- -9.9%
| Period | Period end | Retained Earnings | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (522.4M) | -9.9% |
| FY2024 | 2024-12-31 | (475.27M) | -10.9% |
| FY2023 | 2023-12-31 | (428.39M) | -14.0% |
| FY2022 | 2022-12-31 | (375.92M) | -19.3% |
| FY2021 | 2021-12-31 | (315.11M) | — |
Retained Earnings vs competitors
How RPID compares with its peers on the latest reported figures
- RPID's Mar 2026 retained earnings of -$536.67M is the lowest of the 9 companies compared; the peer median is -$250.59M.
- Its year-over-year change of -10.3% is the 2nd highest of 9, against a peer median of -11.7%.
- Retained earnings amounts to 860.6% of total assets for RPID, versus a peer median of 362.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | -$91.23M | -11.2% | — | 144.8% | |
| Mar 2026 | -$141.24M | +17.2% | — | 213.3% | |
| Mar 2026 | -$155.31M | -21.1% | — | 366.7% | |
| Mar 2026 | -$203.22M | -10.7% | — | 562.3% | |
| Mar 2026 | -$297.96M | -24.3% | — | 874.3% | |
| Mar 2026 | -$311.21M | -17.4% | — | 358.7% | |
| Mar 2026 | -$320.12M | -11.2% | — | 342.2% | |
| Mar 2026 | -$419.01M | -12.1% | — | 812.9% | |
| Mar 2026 | -$536.67M | -10.3% | — | 860.6% | |
| Peer median (excluding RPID) | -$250.59M | -11.7% | — | 362.7% | |
Competitors are the stored peer set for RPID. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 178.39M | 27.06M | 24.29M | 16.91M | 20.03M |
| Short-term Investments | 15.11M | 81.58M | 67.77M | 33.82M | 18.27M |
| Net Receivables | 5.63M | 5.48M | 5.58M | 7.53M | 3.28M |
| Inventory | 15.67M | 21.19M | 19.96M | 20.2M | 17.59M |
| Other Current Assets | 440K | 705K | 577K | 843K | 854K |
| Total Current Assets | 218.12M | 138.58M | 120.42M | 80.92M | 61.17M |
| Property, Plant & Equipment (Net) | 11.3M | 20.88M | 19.07M | 16.36M | 13.08M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 9.97M | 29.79M | 2.91M | 365K | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.78M | 1.4M | 1.05M | 531K | 603K |
| Total Non-current Assets | 23.05M | 52.07M | 23.04M | 17.25M | 13.68M |
| Total Assets | 241.17M | 190.65M | 143.45M | 98.17M | 74.85M |
| Account Payables | 3.94M | 5.43M | 1.97M | 2.54M | 4.14M |
| Short-term Debt | 0 | 0 | 0 | 1.21M | 0 |
| Tax Payables | 781K | 329K | 252K | 235K | 0 |
| Deferred Revenue | 3.31M | 4.71M | 5.97M | 6.6M | 4.73M |
| Other Current Liabilities | 4.04M | 3.74M | 4.95M | 4.62M | 3.25M |
| Total Current Liabilities | 18.17M | 19.05M | 18.99M | 17.57M | 18.49M |
| Long-term Debt | 0 | 0 | 0 | 0 | 18.9M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 2.02M | 229K | 263K | 298K | 583K |
| Total Non-current Liabilities | 2.02M | 7.43M | 6.48M | 5.25M | 23.16M |
| Total Liabilities | 20.19M | 26.48M | 25.46M | 22.82M | 41.65M |
| Common Stock | 415K | 421K | 424K | 430K | 445K |
| Retained Earnings | (315.11M) | (375.92M) | (428.39M) | (475.27M) | (522.4M) |
| Accumulated OCI | (16K) | (1.11M) | (101K) | 39K | 11K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 220.98M | 164.17M | 117.99M | 75.35M | 33.21M |
| Total Debt | 400K | 7.97M | 7.35M | 6.17M | 23.87M |
| Net Debt | (178.39M) | (19.1M) | (16.94M) | (10.74M) | 3.84M |
Rapid Micro Biosystems, Inc.
NASDAQ:RPID
Intrinsic Alpha fair value
Locked
Current Price
$1.11
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.